Anis Febri Nilansari, N. M. Yasin, D. A. Puspandari
{"title":"印度尼西亚日惹班图尔Panembahan Senopati医院住院高血压患者的成本分析:INA-CBGs率与住院实际率的比较","authors":"Anis Febri Nilansari, N. M. Yasin, D. A. Puspandari","doi":"10.55131/jphd/2023/210312","DOIUrl":null,"url":null,"abstract":"Hypertension as a cardiovascular disease ranks first as a disease with the highest expenditure on health insurance costs. In the financing system implemented by the Indonesian Social Security Program, hospitals as health service providers no longer break down bills based on details of services provided, but only by submitting a diagnosis code that comes out in the form of Indonesia Case-Based Groups (INA-CBGs). The INA-CBGs code for mild hypertension with a severity level of 1 is I-4-17-1. The purpose of this study was to determine the implementation of INA-CBGs rates by comparing the cost difference between the INA-CBG rates and the actual hospital rates for inpatients with hypertension code I-4-17-1 with the parameters studied in the form of gender, age, and length of stay, comorbidities, and drug usage. The analytic observational method with a cross-sectional design was used. Data were hospital financial records and patients medical record documents (inpatient hypertension patients) coded I-4-17-I with the following classes; first class, second class, and third class treatment rooms from October 2016 to July 2017 at Panembahan Senopati Hospital. Data were tested for normality with the Kolmogorov-Smirnov test. One Way ANOVA test and t-test were used to analyze the data in determining the difference in costs between the INA-CBGs rates and the actual hospital rates and in determining the factors that influenced the difference in costs. The results showed that 53 patients met the inclusion criteria. The total cost incurred by the hospital for hospitalized hypertensive patients was Rp. 140,963,105, while the total claim rate for INA-CBGs was Rp. 109,960,000. Gender, length of stay, comorbidities, and drug usage were contributed to the difference in cost, while age had no significant effect. It can be concluded that hospitals need to evaluate the implementation of INA-CBGs rates to minimize financial losses.","PeriodicalId":36393,"journal":{"name":"Journal of Public Health and Development","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost analysis of inpatient hypertension patients at Panembahan Senopati Hospital, Bantul, Yogyakarta, Indonesia: comparison between INA-CBGs rates and hospitalized actual rate\",\"authors\":\"Anis Febri Nilansari, N. M. Yasin, D. A. Puspandari\",\"doi\":\"10.55131/jphd/2023/210312\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hypertension as a cardiovascular disease ranks first as a disease with the highest expenditure on health insurance costs. In the financing system implemented by the Indonesian Social Security Program, hospitals as health service providers no longer break down bills based on details of services provided, but only by submitting a diagnosis code that comes out in the form of Indonesia Case-Based Groups (INA-CBGs). The INA-CBGs code for mild hypertension with a severity level of 1 is I-4-17-1. The purpose of this study was to determine the implementation of INA-CBGs rates by comparing the cost difference between the INA-CBG rates and the actual hospital rates for inpatients with hypertension code I-4-17-1 with the parameters studied in the form of gender, age, and length of stay, comorbidities, and drug usage. The analytic observational method with a cross-sectional design was used. Data were hospital financial records and patients medical record documents (inpatient hypertension patients) coded I-4-17-I with the following classes; first class, second class, and third class treatment rooms from October 2016 to July 2017 at Panembahan Senopati Hospital. Data were tested for normality with the Kolmogorov-Smirnov test. One Way ANOVA test and t-test were used to analyze the data in determining the difference in costs between the INA-CBGs rates and the actual hospital rates and in determining the factors that influenced the difference in costs. The results showed that 53 patients met the inclusion criteria. The total cost incurred by the hospital for hospitalized hypertensive patients was Rp. 140,963,105, while the total claim rate for INA-CBGs was Rp. 109,960,000. Gender, length of stay, comorbidities, and drug usage were contributed to the difference in cost, while age had no significant effect. It can be concluded that hospitals need to evaluate the implementation of INA-CBGs rates to minimize financial losses.\",\"PeriodicalId\":36393,\"journal\":{\"name\":\"Journal of Public Health and Development\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Public Health and Development\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55131/jphd/2023/210312\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Public Health and Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55131/jphd/2023/210312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
高血压作为一种心血管疾病,是医疗保险费用支出最高的疾病。在印尼社会保障计划实施的融资体系中,作为医疗服务提供者的医院不再根据所提供服务的细节来分解账单,而只需要提交以印尼病例分组(INA-CBGs)形式出现的诊断代码。严重程度为1级的轻度高血压的INA-CBGs编码为I-4-17-1。本研究的目的是通过比较编码为I-4-17-1的高血压住院患者的INA-CBG费率与实际住院费率之间的成本差异,并以性别、年龄、住院时间、合并症和药物使用为研究参数,来确定INA-CBG费率的实施情况。采用横断面设计的分析观察方法。数据为医院财务记录和患者病历文件(住院高血压患者),编码为I-4-17-I,分类如下:2016年10月至2017年7月,Panembahan Senopati医院的一等、二等和三等治疗室。用Kolmogorov-Smirnov检验检验数据的正态性。采用单因素方差分析(One - Way ANOVA)检验和t检验对数据进行分析,以确定INA-CBGs率与实际医院率之间的成本差异,并确定影响成本差异的因素。结果显示53例患者符合纳入标准。医院对住院高血压患者的总费用为140,963,105卢比,而INA-CBGs的总索赔率为109,96万卢比。性别、住院时间、合并症和药物使用对成本差异有影响,而年龄没有显著影响。可以得出结论,医院需要评估INA-CBGs费率的实施情况,以尽量减少财务损失。
Cost analysis of inpatient hypertension patients at Panembahan Senopati Hospital, Bantul, Yogyakarta, Indonesia: comparison between INA-CBGs rates and hospitalized actual rate
Hypertension as a cardiovascular disease ranks first as a disease with the highest expenditure on health insurance costs. In the financing system implemented by the Indonesian Social Security Program, hospitals as health service providers no longer break down bills based on details of services provided, but only by submitting a diagnosis code that comes out in the form of Indonesia Case-Based Groups (INA-CBGs). The INA-CBGs code for mild hypertension with a severity level of 1 is I-4-17-1. The purpose of this study was to determine the implementation of INA-CBGs rates by comparing the cost difference between the INA-CBG rates and the actual hospital rates for inpatients with hypertension code I-4-17-1 with the parameters studied in the form of gender, age, and length of stay, comorbidities, and drug usage. The analytic observational method with a cross-sectional design was used. Data were hospital financial records and patients medical record documents (inpatient hypertension patients) coded I-4-17-I with the following classes; first class, second class, and third class treatment rooms from October 2016 to July 2017 at Panembahan Senopati Hospital. Data were tested for normality with the Kolmogorov-Smirnov test. One Way ANOVA test and t-test were used to analyze the data in determining the difference in costs between the INA-CBGs rates and the actual hospital rates and in determining the factors that influenced the difference in costs. The results showed that 53 patients met the inclusion criteria. The total cost incurred by the hospital for hospitalized hypertensive patients was Rp. 140,963,105, while the total claim rate for INA-CBGs was Rp. 109,960,000. Gender, length of stay, comorbidities, and drug usage were contributed to the difference in cost, while age had no significant effect. It can be concluded that hospitals need to evaluate the implementation of INA-CBGs rates to minimize financial losses.